Skip to main content

Research Repository

Advanced Search

Achieving improved permeability by hydrogen bond donor modulation in a series of MGAT2 inhibitors

Scott, J.S.; Berry, D.J.; Brown, H.S.; Buckett, L.; Clarke, D.S.; Goldberg, K.; Hudson, J.A.; Leach, A.G.; MacFaul, P.A.; Rauboa, P.; Robb, G.

Achieving improved permeability by hydrogen bond donor modulation in a series of MGAT2 inhibitors Thumbnail


Authors

J.S. Scott

D.J. Berry

H.S. Brown

L. Buckett

D.S. Clarke

K. Goldberg

J.A. Hudson

A.G. Leach

P.A. MacFaul

P. Rauboa

G. Robb



Abstract

Monoacylglycerolacetyltransferase-2 (MGAT2) is a potential target for the treatment of type II diabetes. We report here the optimisation of a series of MGAT2 inhibitors with regard to their potency and permeability. Improvements in permeability, as measured by increased flux in a Caco-2 assay, were achieved through substitution at the 9-position of the core. We propose that reduction of the NH hydrogen-bond donor strength was primarily responsible for these effects.

Citation

Scott, J., Berry, D., Brown, H., Buckett, L., Clarke, D., Goldberg, K., …Robb, G. (2013). Achieving improved permeability by hydrogen bond donor modulation in a series of MGAT2 inhibitors. MedChemComm, 4(9), 1305-1311. https://doi.org/10.1039/c3md00156c

Journal Article Type Article
Publication Date Sep 1, 2013
Deposit Date Sep 3, 2013
Publicly Available Date Mar 28, 2024
Journal MedChemComm.
Print ISSN 2040-2503
Electronic ISSN 2040-2511
Publisher Royal Society of Chemistry
Peer Reviewed Peer Reviewed
Volume 4
Issue 9
Pages 1305-1311
DOI https://doi.org/10.1039/c3md00156c

Files




You might also like



Downloadable Citations